TL
Talis Biomedical Corporation
TLIS · OTC
$2.84 +0.00% (+$0.00)
Market Cap $5.18M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
50 /100
Fair P/S 12.57x
P/B 0.07x
P/E N/A
Growth
0 /100
Declining Rev. growth 66.48%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 90.05%
Net margin 15,050.20%
Op. margin 16,217.20%
Quality
0 /100
Poor ROIC 75.26%
ROA 65.50%
Asset turnover 0.00x
Debt
96 /100
Low Debt/Equity 0.28x
Current ratio 8.86x
Net debt/EBITDA 0.86x
Stability
61 /100
Moderate Beta 1.32x
EPS volatility 7.03%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre TLIS
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Rebecca Markovich
Employees
99
Headquarters
Menlo Park